Zobrazeno 1 - 10
of 114
pro vyhledávání: '"Patrice Chevallier"'
Autor:
Catherine Willem, Zakia Djaoud, Thierry Guillaume, Gaëlle David, Nolwenn Legrand, Patrice Chevallier, Katia Gagne, Alexandre Walencik, Christelle Retière, Pierre Mérieau
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
Scientific Reports
Scientific Reports, 2021, 11 (1), pp.15782. ⟨10.1038/s41598-021-95245-7⟩
Scientific Reports, Nature Publishing Group, 2021, 11 (1), pp.15782. ⟨10.1038/s41598-021-95245-7⟩
Scientific Reports
Scientific Reports, 2021, 11 (1), pp.15782. ⟨10.1038/s41598-021-95245-7⟩
Scientific Reports, Nature Publishing Group, 2021, 11 (1), pp.15782. ⟨10.1038/s41598-021-95245-7⟩
KIR are mainly expressed on NK cells and to a lesser extent on T lymphocytes. Although the KIR NK cell repertoire was well explored in haploidentical Hematopoietic Stem Cell Transplantation (HSCT), KIR T cell compartment remains to be investigated in
Publikováno v:
Cancers
Cancers, 2021, 13 (15), pp.3767. ⟨10.3390/cancers13153767⟩
Cancers, MDPI, 2021, 13 (15), pp.3767. ⟨10.3390/cancers13153767⟩
Cancers, Vol 13, Iss 3767, p 3767 (2021)
Cancers, 2021, 13 (15), pp.3767. ⟨10.3390/cancers13153767⟩
Cancers, MDPI, 2021, 13 (15), pp.3767. ⟨10.3390/cancers13153767⟩
Cancers, Vol 13, Iss 3767, p 3767 (2021)
Simple Summary Immunotherapies are promising approaches to curing different acute leukemias. Natural killer (NK) cells are lymphocytes that are efficient in the elimination of leukemic cells. NK-cell-based immunotherapies are particularly attractive,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d33db34648f1a84c8c538a2a1d8e9313
https://www.hal.inserm.fr/inserm-03317983
https://www.hal.inserm.fr/inserm-03317983
Autor:
Audrey Grain, Margaux Camuset, Marie C. Béné, Marion Eveillard, Béatrice Clémenceau, Alice Huault, Caroline Thomas, Fanny Rialland, Patrice Chevallier
Publikováno v:
Hematological Oncology
Hematological Oncology, 2021, 39 (2), pp.270-272. ⟨10.1002/hon.2799⟩
Hematological Oncology, Wiley, 2021, 39 (2), pp.270-272. ⟨10.1002/hon.2799⟩
Hematological Oncology, 2021, 39 (2), pp.270-272. ⟨10.1002/hon.2799⟩
Hematological Oncology, Wiley, 2021, 39 (2), pp.270-272. ⟨10.1002/hon.2799⟩
Relapsed B-lineage acute lymphoblastic leukemia (ALL) in children is associated with poor prognosis. Therefore, it seems essential to stratify patients according to prognostic factors in order to adapt therapies. The evaluation of minimal/measurable
Autor:
Catherine A. Tuglus, Nicola Gökbuget, Ellen K. Ritchie, Anthony S. Stein, Nicolas Boissel, J. Morris, Patrice Chevallier, Alessandro Rambaldi, Cristina Papayannidis, Oliver G. Ottmann, Giovanni Martinelli
Aim\udTo evaluate long-term durability of blinatumomab, a BiTE® (bispecific T-cell engager) molecule, in adults with relapsed/refractory (R/R) Philadelphia chromosome–positive (Ph+) B-cell precursor acute lymphoblastic leukaemia (ALL).\udMethods\u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7aef52ace83dbc202c6c3270f3a866e1
Autor:
Dhon Roméo Makanga, Catherine Willem, Marie C. Béné, Alice Garnier, Thierry Guillaume, Katia Gagne, Anne Cesbron, Nolwenn Legrand, Christelle Retière, Bercelin Maniangou, Amandine Le Bourgeois, Patrice Chevallier, Pierre Peterlin
Publikováno v:
Journal of Immunology
Journal of Immunology, 2019, 202 (7), pp.2141-2152. ⟨10.4049/jimmunol.1801489⟩
Journal of Immunology, Publisher : Baltimore : Williams & Wilkins, c1950-. Latest Publisher : Bethesda, MD : American Association of Immunologists, 2019, 202 (7), pp.2141-2152. ⟨10.4049/jimmunol.1801489⟩
Journal of Immunology, 2019, 202 (7), pp.2141-2152. ⟨10.4049/jimmunol.1801489⟩
Journal of Immunology, Publisher : Baltimore : Williams & Wilkins, c1950-. Latest Publisher : Bethesda, MD : American Association of Immunologists, 2019, 202 (7), pp.2141-2152. ⟨10.4049/jimmunol.1801489⟩
P.C. and C.R. have equally contributed to this work; International audience; Little is known regarding the effect of KIR/HLA incompatibilities (inc.) in the setting of T-replete haploidentical allogeneic he-matopoietic stem cell transplantation using
Autor:
Harry C. Schouten, Myriam Labopin, Jordi Esteve, Arnon Nagler, Xavier Poiré, Didier Blaise, Johan Maertens, Patrice Chevallier, Tsila Zuckerman, Norbert Ifrah, Gabriela M. Baerlocher, Emmanuelle Polge, Mohamad Mohty, Eric Deconinck, Edouard Forcade, Liisa Volin, Alessandro Rambaldi
Publikováno v:
American journal of hematology, Vol. 94, no. 2, p. 231-239 (2019)
American Journal of Hematology, 94(2), 231-239. Wiley
American journal of hematology
American journal of hematology, 2018, 94 (2), pp.231-239. ⟨10.1002/ajh.25355⟩
American Journal of Hematology, 94(2), 231-239. Wiley
American journal of hematology
American journal of hematology, 2018, 94 (2), pp.231-239. ⟨10.1002/ajh.25355⟩
International audience; Acute myeloid leukemia (AML) in first remission (CR1) with isolated NPM1 mutation (iNPM1m) is considered a good prognosis genotype, although up to one-third relapse. To evaluate the best transplant strategy, we retrospectively
Autor:
Jean Bourhis, Mohamad Mohty, Audrey Mailhol, Johan Maertens, Hélène Labussière-Wallet, Jürgen Finke, Bipin N. Savani, Didier Blaise, Dietrich W. Beelen, Catherine J. Lee, Maija Itälä-Remes, Ibrahim Yakoub-Agha, Arnon Nagler, Myriam Labopin, Patrice Chevallier, Arnold Ganser
Publikováno v:
American Journal of Hematology. 94:431-438
Therapy-related acute myeloid leukemia (t-AML) arises as a late complication following antecedent solid tumors or hematologic diseases and their associated treatments. There are limited data regarding risk factors and outcomes following allogeneic he
Autor:
Philippe Moreau, Nicolas Blin, Thierry Guillaume, Alice Garnier, Cyrille Touzeau, Beatrice Mahe, Steven Le Gouill, Patrice Chevallier, Thomas Gastinne, Anne Lok, Pierre Peterlin, Viviane Dubruille, Marie C. Béné, Yannick Le Bris, Amandine Le Bourgeois
Publikováno v:
Oncotarget
// Patrice Chevallier 1 , Pierre Peterlin 1 , Alice Garnier 1 , Amandine Le Bourgeois 1 , Beatrice Mahe 1 , Viviane Dubruille 1 , Nicolas Blin 1 , Cyrille Touzeau 1 , Thomas Gastinne 1 , Anne Lok 1 , Yannick Le Bris 2 , Marie C. Bene 2 , Steven Le Go
Autor:
Olivier Theisen, Pierre Peterlin, Viviane Dubruille, Patrice Chevallier, Pascal Godmer, Amandine Le Bourgeois, Sylvain Thepot, Anne Parcelier, Marion Loirat, Steven Le Gouill, Adrien Trebouet, Damien Luque Paz, Mélanie Mercier, S. Vigouroux, Mathilde Hunault, Céline Bossard, Marie C. Béné, Marion Eveillard, Audrey Ménard, Alice Garnier, Nadine Morineau, Camille Debord, Hervé Maisonneuve, François Subiger, Catherine Godon, Yannick Le Bris, Elsa Lestang, Jacques Delaunay, Sophie Vantyghem, Soraya Wuilleme, Anne Moreau, Ronan Le Calloch, Philippe Moreau, Lenaïg Le Clech, Thierry Guillaume, Bruno Villemagne, Valérie Ugo
Publikováno v:
Haematologica
Haematologica, Ferrata Storti Foundation, 2021, 106 (3), pp.701-707. ⟨10.3324/haematol.2019.242677⟩
Haematologica, 2021, 106 (3), pp.701-707. ⟨10.3324/haematol.2019.242677⟩
Haematologica, Ferrata Storti Foundation, 2021, 106 (3), pp.701-707. ⟨10.3324/haematol.2019.242677⟩
Haematologica, 2021, 106 (3), pp.701-707. ⟨10.3324/haematol.2019.242677⟩
Next-generation sequencing (NGS) is used to investigate the presence of somatic mutations. The utility of incorporating routine sequencing to guide diagnosis and therapeutic decisions remains unclear. We report the findings of an observational, multi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc0be57440bd0d6c4e085cb31faf4d12
https://www.hal.inserm.fr/inserm-02552097
https://www.hal.inserm.fr/inserm-02552097
Autor:
Marie Angoso, Yves Chalandon, Anne Huynh, Justyna Kanold, Thomas Remen, Cécile Pochon, Anne Sirvent, Eolia Brissot, Faezeh Izzadifar-Legrand, Yves Beguin, Edouard Forcade, Bénédicte Neven, Stéphanie Nguyen, Eliane Albuisson, Marie-Thérèse Rubio, Patrice Chevallier, Marie Balza, Mauricette Michallet, Anne-Lise Ménard, Fanny Rialland, Marie Y Detrait, Nicole Raus, Jean-Hugues Dalle, Cecile Renard, Fanny Gonzales, Catherine Paillard, Jacques-Olivier Bay, Claude Eric Bulabois, Gérard Michel, Pascale Schneider, Ibrahim Yakoub-Agha, Nathalie Dhedin, Jérôme Cornillon, Ali Bazarbachi
Publikováno v:
Journal of cancer research and clinical oncology (2021)
Journal of Cancer Research and Clinical Oncology
Journal of Cancer Research and Clinical Oncology, 2021, ⟨10.1007/s00432-021-03761-w⟩
Journal of Cancer Research and Clinical Oncology, Springer Verlag, 2021, ⟨10.1007/s00432-021-03761-w⟩
Journal of Cancer Research and Clinical Oncology
Journal of Cancer Research and Clinical Oncology, 2021, ⟨10.1007/s00432-021-03761-w⟩
Journal of Cancer Research and Clinical Oncology, Springer Verlag, 2021, ⟨10.1007/s00432-021-03761-w⟩
Background There are currently few data on the outcome of acute myeloid leukemia (AML) in adolescents after allogeneic HSCT. The aim of this study is to describe the outcome and its specific risk factors for children, adolescents and young adults aft
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd62a4f5b95be88adf6a749bf838849f
https://archive-ouverte.unige.ch/unige:160534
https://archive-ouverte.unige.ch/unige:160534